Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based studySatveer K. Mahil, Anthony Bewley, Teresa Tsakok et al.|Journal of Allergy and Clinical Immunology|2020Cited by 160
Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational studyMarina Talamonti, Marco Galluzzo, Andrea Chiricozzi et al.|Expert Opinion on Biological Therapy|2020Cited by 43
Management of patients with atopic dermatitis undergoing systemic therapy during COVID‐19 pandemic in Italy: Data from the DA‐COVID‐19 registryAndrea Chiricozzi, Clara De Simone, Marco Galluzzo et al.|Allergy|2021Cited by 37